Advertisement

Nucleus matrix antigen

  • S. HoldenriederEmail author
  • P. Stieber
Chapter
Part of the Springer Reference Medizin book series (SRM)

Literatur

  1. Hasholzner U, Stieber P, Zimmermann A et al (1999) Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases. Anticancer Res 19:2415–2420PubMedPubMedCentralGoogle Scholar
  2. Mahnert B et al (2003) Measurements of complement factor H-related protein (BTA-TRAK Assay) and nuclear matrix protein (NMP22 Assay) – useful diagnostic tools in the diagnosis of urinary bladder cancer? Clin Chem Lab Med 41:104–110PubMedCrossRefGoogle Scholar
  3. Sturgeon CM, Duffy MJ, Hofmann BR et al (2010) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 56:e1–48PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Institut für LaboratoriumsmedizinDeutsches Herzzentrum München, Klinik an der Technischen Universität MünchenMünchenDeutschland
  2. 2.Institut für LaboratoriumsmedizinKlinikum der Universität München (LMU)MünchenDeutschland

Personalised recommendations